Abstract:Objective— By excreting cellular cholesterol to apolipoprotein A-I, ATP-binding cassette transporter A1 (ABCA1) mediates the biogenesis of high-density lipoprotein in hepatocytes and prevents foam cell formation from macrophages. We recently showed that cell surface–resident ABCA1 (csABCA1) undergoes ubiquitination and later lysosomal degradation through the endosomal sorting complex required for transport system. Herein, we investigated the relevance of this degradation pathway to the turnover of csABCA1 in hypercholesterolemia. Approach and Results— Immunoprecipitation and cell surface-biotinylation studies with HepG2 cells and mouse peritoneal macrophages showed that the ubiquitination level and degradation of csABCA1 were facilitated by treatment with a liver X receptor (LXR) agonist and acetylated low-density lipoprotein. The effects of an LXR agonist and acetylated low-density lipoprotein on the degradation of csABCA1 were repressed completely by treatment with bafilomycin, an inhibitor of lysosomal degradation, and by depletion of tumor susceptibility gene 101, a major component of endosomal sorting complex required for transport-I. RNAi analysis indicated that LXRβ inhibited the accelerated lysosomal degradation of csABCA1 by the LXR agonist, regardless of its transcriptional activity. Cell surface coimmunoprecipitation with COS1 cells expressing extracellularly hemagglutinin-tagged ABCA1 showed that LXRβ interacted with csABCA1 and inhibited the ubiquitination of csABCA1. Immunoprecipitates with anti-ABCA1 antibodies from the liver plasma membranes showed less LXRβ and a higher ubiquitination level of ABCA1 in high-fat diet–fed mice than in normal chow-fed mice. Conclusions— Under conditions of high cellular cholesterol content, csABCA1 became susceptible to ubiquitination by dissociation of LXRβ from csABCA1, which facilitated the lysosomal degradation of csABCA1 through the endosomal sorting complex required for transport system.

A novel conserved targeting motif found in ABCA transporters mediates trafficking to early post-Golgi compartments

Disruption of N-linked Glycosylation Promotes Proteasomal Degradation of the Human ATP-binding Cassette Transporter ABCA3

Identification of an amino acid residue in ATP-binding cassette transport G1 critical for mediating cholesterol efflux

Structural Basis For Substrate Specificity Of An Amino Acid Abc Transporter

Differential phospholipid substrates and directional transport by ATP-binding cassette proteins ABCA1, ABCA7, and ABCA4 and disease-causing mutants

Small GTPase ARF6 Regulates Endocytic Pathway Leading to Degradation of ATP-Binding Cassette Transporter A1

Structure of the Human Lipid Exporter ABCA1

A Proximity Complementation Assay to Identify Small Molecules That Enhance the Traffic of ABCA4 Misfolding Variants

Molecular Diffusion of ABCA1 at the Cell Surface of Living Cells Assessed by svFCS

Structure and transport mechanism of the human cholesterol transporter ABCG1

Molecular structure of a novel cholesterol-responsive A subclass ABC transporter, ABCA9

Gene expression of A6-like subgroup of ATP-binding cassette transporters in mouse brain parenchyma and microvessels

Structural basis of substrate recognition and translocation by human very long-chain fatty acid transporter ABCD1

Molecular basis of cholesterol efflux via ABCG subfamily transporters

Cellular Cholesterol Accumulation Facilitates Ubiquitination and Lysosomal Degradation of Cell Surface–Resident ABCA1

The net electrostatic potential and hydration of ABCG2 affect substrate transport

Structural basis of substrate recognition and translocation by human ABCD1

Regulation of the Function of the Human ABCG2 Multidrug Transporter by Cholesterol and Bile Acids: Effects of Mutations in Potential Substrate and Steroid Binding Sites

Single-nucleotide polymorphisms in a short basic motif in the ABC transporter ABCG2 disable its trafficking out of endoplasmic reticulum and reduce cell resistance to anticancer drugs

Functional characterization of missense variants affecting the extracellular domains of ABCA1 using a fluorescence-based assay